Background The Arimidex, Tamoxifen, Alone or in Combination (ATAC) trial was designed to compare ... more Background The Arimidex, Tamoxifen, Alone or in Combination (ATAC) trial was designed to compare the effi cacy and safety of anastrozole (1 mg) with tamoxifen (20 mg), both given orally every day for 5 years, as adjuvant treatment for postmenopausal women with early-stage breast cancer. In this analysis, we assess the long-term outcomes after a median follow-up of 120 months.
Background The Arimidex, Tamoxifen, Alone or in Combination (ATAC) trial was designed to compare ... more Background The Arimidex, Tamoxifen, Alone or in Combination (ATAC) trial was designed to compare the effi cacy and safety of anastrozole (1 mg) with tamoxifen (20 mg), both given orally every day for 5 years, as adjuvant treatment for postmenopausal women with early-stage breast cancer. In this analysis, we assess the long-term outcomes after a median follow-up of 120 months.
Uploads
Papers by John Forbes